RE:Moreover how many of you knowInteresting that Lmnl has applied for govt funding to do a Covid plasma study when the company has eliminated all R&D regarding plasma proteins. Given that the company does not yet have an approved manufacturing facility, I doubt whether Lmnl will be a preferred partner to undertake the research required. It would have been more interesting if an application of plAsminogen to help patients suffering from acute respiratory distress in intensive care was being investigated as this would complement the upcoming bla refiling.